UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias

Bone marrow transplantation (Basingstoke), 2003-09, Vol.32 (6), p.549-556

2003

Volltextzugriff (PDF)

Radioimmunotherapy with alpha-emitting nuclides

European journal of nuclear medicine, 1998-09, Vol.25 (9), p.1341-1351

1998

Volltextzugriff (PDF)

Molecular Remission Induction with Retinoic Acid and Anti-CD33 Monoclonal Antibody HuM195 in Acute Promyelocytic Leukemia

Clinical cancer research, 2000-02, Vol.6 (2), p.372-380

2000

Volltextzugriff (PDF)

A Phase I Trial of Humanized Monoclonal Antibody HuM195 (anti-CD33) with Low-Dose Interleukin 2 in Acute Myelogenous Leukemia

Clinical cancer research, 1999-10, Vol.5 (10), p.2748-2755

1999

Volltextzugriff (PDF)

S166: MAGROLIMAB IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH UNTREATED HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (HR MDS): 5F9005 PHASE 1B STUDY RESULTS

HemaSphere, 2022-06, Vol.6, p.67-68

2022

Volltextzugriff (PDF)

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia : specific targeting without immunogenicity

Blood, 1994-04, Vol.83 (7), p.1760-1768

1994

Volltextzugriff (PDF)

Ab therapy of AML: native anti-CD33 Ab and drug conjugates

Cytotherapy (Oxford, England), 2008, Vol.10 (1), p.7-12

Jurcic, J.G., MD

2008

Volltextzugriff (PDF)

Parametric Images of Antibody Pharmacokinetics in Bi213-HuM195 Therapy of Leukemia

The Journal of nuclear medicine (1978), 2001-01, Vol.42 (1), p.27-32

2001

Volltextzugriff (PDF)

Antibody therapy of acute myelogenous leukemia

Cancer biotherapy & radiopharmaceuticals, 2000-08, Vol.15 (4), p.319-326

JURCIC, Joseph G

2000

Volltextzugriff (PDF)

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Haematologica (Roma), 2016-06, Vol.101 (6), p.781-788

2016

Volltextzugriff (PDF)

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia

Haematologica (Roma), 2013-01, Vol.98 (1), p.119-128

2013

Volltextzugriff (PDF)

Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

Blood, 2001-11, Vol.98 (9), p.2651-2656

2001

Volltextzugriff (PDF)

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

The New England journal of medicine, 2020-01, Vol.382 (2), p.140-151

2020

Volltextzugriff (PDF)

Antibody therapy for residual disease in acute myelogenous leukemia

Critical reviews in oncology/hematology, 2001-04, Vol.38 (1), p.37-45

Jurcic, Joseph G.

2001

Volltextzugriff (PDF)

Monoclonal antibody therapy of APL

Current topics in microbiology and immunology, 2007-01, Vol.313, p.205

2007

Volltextzugriff (PDF)

Radioimmunotherapy of hematological cancer : problems and progress

Clinical cancer research, 1995-12, Vol.1 (12), p.1439-1446

1995

Volltextzugriff (PDF)

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195

Leukemia, 1995-02, Vol.9 (2), p.244-248

1995

Volltextzugriff (PDF)

Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias

Cancer research (Chicago, Ill.), 1995-12, Vol.55 (23 Suppl), p.5908s

1995

Volltextzugriff (PDF)

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1575-1581

2006

Volltextzugriff (PDF)

Refractory aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin

Cancer, 2003-02, Vol.97 (4), p.1025-1032

2003

Volltextzugriff (PDF)

Excretion of Ascaris lumbricoides during total body irradiation

Bone marrow transplantation (Basingstoke), 1994-04, Vol.13 (4), p.491-493

1994

Volltextzugriff (PDF)

Targeted a particle immunotherapy for myeloid leukemia

Blood, 2002-08, Vol.100 (4), p.1233-1239

2002

Volltextzugriff (PDF)

Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.6593-6593

2011

Volltextzugriff (PDF)

The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

BLOOD, 2018-11, Vol.132 (Supplement 1), p.1-1

2018

Volltextzugriff (PDF)

Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches

Current opinion in hematology, 2000-07, Vol.7 (4), p.247-254

2000

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(111)
Buchkapitel
(3)

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

Humans
(54)
Life Sciences & Biomedicine
(45)
Science & Technology
(45)
Antibodies, Monoclonal - Therapeutic Use
(25)
Oncology
(25)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Female
(23)
Adult
(22)
Middle Aged
(22)
Male
(21)
Aged
(20)
Hematology
(17)
Radioimmunotherapy
(15)
Animals
(14)
Treatment Outcome
(13)
Pharmacology. Drug Treatments
(12)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Aged, 80 And Over
(10)
Antineoplastic Agents
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias

Radioimmunotherapy with alpha-emitting nuclides

Molecular Remission Induction with Retinoic Acid and Anti-CD33 Monoclonal Antibody HuM195 in Acute Promyelocytic Leukemia

A Phase I Trial of Humanized Monoclonal Antibody HuM195 (anti-CD33) with Low-Dose Interleukin 2 in Acute Myelogenous Leukemia

S166: MAGROLIMAB IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH UNTREATED HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (HR MDS): 5F9005 PHASE 1B STUDY RESULTS

A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia : specific targeting without immunogenicity

Ab therapy of AML: native anti-CD33 Ab and drug conjugates

Parametric Images of Antibody Pharmacokinetics in Bi213-HuM195 Therapy of Leukemia

Antibody therapy of acute myelogenous leukemia

Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia

Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemia

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Antibody therapy for residual disease in acute myelogenous leukemia

Monoclonal antibody therapy of APL

Radioimmunotherapy of hematological cancer : problems and progress

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195

Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia

Refractory aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin

Excretion of Ascaris lumbricoides during total body irradiation

Targeted a particle immunotherapy for myeloid leukemia

Decitabine for the treatment of acute myeloid leukemia (AML): Memorial Sloan-Kettering Cancer Center experience

The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches

Suchergebnisse filtern